Physician profile

Lori H Cavender

Obstetrics & Gynecology · Houston, TX

NPI 1285955419

$2,489.47

in general payments reported to CMS, 2019-2025

38 companies · $513 in 2025

The $513 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,427.02

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $380.79 2019-2025 Veozah
Abbvie INC. $210.41 2019-2023 Lo Loestrin Fe
Evofem Biosciences, INC. $197.52 2022-2025 Phexxi, Solosec, Phexx
Mayne Pharma Commercial LLC $120.48 2022-2023
Sumitomo Pharma America, INC. $116.01 2023-2025 Myfembree, Gemtesa
Bayer Healthcare Pharmaceuticals INC. $113.90 2019-2025
Pfizer INC. $107.53 2019-2022
Coopersurgical, INC. $93.08 2019-2024 Paragard T 380a
Exeltis, USA INC. $90.36 2019-2025 Slynd
Therapeuticsmd, INC. $90.27 2019-2022
Baxter Healthcare $82.40 2023-2024 Tisseel, Perclot
Lupin INC. $80.85 2019-2020
Shield Therapeutics INC $75.70 2023 Accrufer
Myovant Sciences INC. $68.95 2022
Medtronic, INC. $67.46 2025 Signia
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Organon LLC $57.65 2022-2024
Octapharma USA, INC. $39.76 2025 Fibryga
Daiichi Sankyo INC. $38.41 2019
Avion Pharmaceuticals $37.29 2019-2023 Balcoltra
Aspira Women'S Health INC $36.79 2020-2024 Ova1
Duchesnay USA Incorporated $33.88 2019
Meditrina $31.35 2022-2024
Amag Pharmaceuticals, INC. $31.01 2019
Bluewind Medical $29.14 2025 Revi
Pacira Pharmaceuticals Incorporated $28.21 2023 Exparel
Biogen, INC. $26.19 2025 Zurzuvae
Mimedx Group, INC. $22.64 2024
Minerva Surgical, INC $22.40 2019
Dexcom, INC. $21.38 2025 Dexcom G6 Transmitter
Mylan Pharmaceuticals INC. $20.02 2022
Dilon Technologies, INC. $19.69 2025 Hemoblast Bellows
Boston Scientific Corporation $18.86 2025 Axonics
Exact Sciences Corporation $16.30 2023 Cologuard Collection Kit
Millicent US INC $15.23 2024 Intrarosa, Femring
Olympus America INC. $13.68 2019
Molnlycke Health Care US, LLC $11.78 2019
Allergan, INC. $11.05 2019
Renovia INC $11.05 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lori H Cavender

$2,489.47

in general payments reported 2019-2025

Years
2019-2025
Top company
Astellas Pharma US INC
Context
The $513 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/970257/lori-h-cavender

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.